Illumina Investor
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Acquisitions Number:
Made Acquisitions
Investors Number:
19
Total Funding:
778000000.0
Technology:
Neurological Disorders
Estimated Revenue:
$500M to $1B
Employee Number:
5001-10000
Investment Stage:
Early Stage Venture, Late Stage Venture
Industry:
Biotechnology, Genetics, Health Care, Medical
Founded Date:
1998-01-01
Headquarters:
San Diego, California, United States
Number Of Exists:
6
Last Funding Date:
2023-01-04
Last Funding Type:
Post-IPO Debt
Investor Type:
Accelerator
Funding Status:
IPO